These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
338 related articles for article (PubMed ID: 31456803)
1. CD8 Uzhachenko RV; Shanker A Front Immunol; 2019; 10():1906. PubMed ID: 31456803 [TBL] [Abstract][Full Text] [Related]
2. The analysis of the natural killer-like activity of human cytolytic T lymphocytes revealed HLA-E as a novel target for TCR alpha/beta-mediated recognition. Pietra G; Romagnani C; Falco M; Vitale M; Castriconi R; Pende D; Millo E; Anfossi S; Biassoni R; Moretta L; Mingari MC Eur J Immunol; 2001 Dec; 31(12):3687-93. PubMed ID: 11745389 [TBL] [Abstract][Full Text] [Related]
3. HLA-E-restricted recognition of human cytomegalovirus by a subset of cytolytic T lymphocytes. Romagnani C; Pietra G; Falco M; Mazzarino P; Moretta L; Mingari MC Hum Immunol; 2004 May; 65(5):437-45. PubMed ID: 15172443 [TBL] [Abstract][Full Text] [Related]
4. Killer cell inhibitory receptors for MHC class I molecules regulate lysis of melanoma cells mediated by NK cells, gamma delta T cells, and antigen-specific CTL. Bakker AB; Phillips JH; Figdor CG; Lanier LL J Immunol; 1998 Jun; 160(11):5239-45. PubMed ID: 9605119 [TBL] [Abstract][Full Text] [Related]
5. Cellular mechanisms of lymphocyte-mediated lysis of tumor cells. Arancia G; Malorni W; Donelli G Ann Ist Super Sanita; 1990; 26(3-4):369-84. PubMed ID: 2151107 [TBL] [Abstract][Full Text] [Related]
6. A novel beta 4, alpha 6 integrin-associated epithelial cell antigen involved in natural killer cell and antigen-specific cytotoxic T lymphocyte cytotoxicity. Phillips JH; McKinney L; Azuma M; Spits H; Lanier LL J Exp Med; 1991 Dec; 174(6):1571-81. PubMed ID: 1744585 [TBL] [Abstract][Full Text] [Related]
7. Expression of HLA-C molecules confers target cell resistance to some non-major histocompatibility complex-restricted T cells in a manner analogous to allospecific natural killer cells. Falk CS; Steinle A; Schendel DJ J Exp Med; 1995 Oct; 182(4):1005-18. PubMed ID: 7561674 [TBL] [Abstract][Full Text] [Related]
8. Teleost T and NK cell immunity. Fischer U; Koppang EO; Nakanishi T Fish Shellfish Immunol; 2013 Aug; 35(2):197-206. PubMed ID: 23664867 [TBL] [Abstract][Full Text] [Related]
9. Re-targeting of cytotoxic T lymphocytes and/or natural killer cells to CEA-expressing tumor cells with anti-CEA antibody activity. Kuroki M; Hachimine K; Huang J; Shibaguchi H; Kinugasa T; Maekawa S; Kuroki M Anticancer Res; 2005; 25(6A):3725-32. PubMed ID: 16302732 [TBL] [Abstract][Full Text] [Related]
11. Glu227-->Lys substitution in the acidic loop of major histocompatibility complex class I alpha 3 domain distinguishes low avidity CD8 coreceptor and avidity-enhanced CD8 accessory functions. Shen L; Potter TA; Kane KP J Exp Med; 1996 Nov; 184(5):1671-83. PubMed ID: 8920857 [TBL] [Abstract][Full Text] [Related]
12. Control of self-reactive cytotoxic T lymphocytes expressing gamma delta T cell receptors by natural killer inhibitory receptors. Halary F; Peyrat MA; Champagne E; Lopez-Botet M; Moretta A; Moretta L; Vié H; Fournié JJ; Bonneville M Eur J Immunol; 1997 Nov; 27(11):2812-21. PubMed ID: 9394804 [TBL] [Abstract][Full Text] [Related]
13. HER-2/neu-derived peptide epitopes are also recognized by cytotoxic CD3(+)CD56(+) (natural killer T) lymphocytes. Baxevanis CN; Gritzapis AD; Tsitsilonis OE; Katsoulas HL; Papamichail M Int J Cancer; 2002 Apr; 98(6):864-72. PubMed ID: 11948464 [TBL] [Abstract][Full Text] [Related]
14. Strategies to endow cytotoxic T lymphocytes or natural killer cells with antibody activity against carcinoembryonic antigen. Kuroki M; Kuroki M; Shibaguchi H; Badran A; Hachimine K; Zhang J; Kinugasa T Tumour Biol; 2004; 25(4):208-16. PubMed ID: 15557759 [TBL] [Abstract][Full Text] [Related]
15. A novel target cell antigen involved in the NK-like lytic activity of antigen-specific cytotoxic T lymphocytes. Harris DT; Jaso-Friedmann L; Evans DL Immunol Lett; 1993 Sep; 38(1):11-8. PubMed ID: 8300148 [TBL] [Abstract][Full Text] [Related]
16. Identification of effector-memory CMV-specific T lymphocytes that kill CMV-infected target cells in an HLA-E-restricted fashion. Mazzarino P; Pietra G; Vacca P; Falco M; Colau D; Coulie P; Moretta L; Mingari MC Eur J Immunol; 2005 Nov; 35(11):3240-7. PubMed ID: 16224817 [TBL] [Abstract][Full Text] [Related]
17. Cell surface molecules involved in NK recognition by cloned cytotoxic T lymphocytes. Brooks CG; Holscher M J Immunol; 1987 Mar; 138(5):1331-7. PubMed ID: 3543127 [TBL] [Abstract][Full Text] [Related]
18. Locally superantigen-activated peritoneal cytolytic T lymphocytes belong to the CD8+ CD45RC- subset and lyse MHC class II+ tumor cells. Hansson J; Ericsson PO; Dohlsten M; Sjögren HO; Kalland T; Hedlund G Immunol Lett; 1992 Dec; 34(3):229-36. PubMed ID: 1487309 [TBL] [Abstract][Full Text] [Related]
19. Receptors and lytic mediators regulating anti-tumor activity by the leukemic killer T cell line TALL-104. Brando C; Mukhopadhyay S; Kovacs E; Medina R; Patel P; Catina TL; Campbell KS; Santoli D J Leukoc Biol; 2005 Aug; 78(2):359-71. PubMed ID: 15937142 [TBL] [Abstract][Full Text] [Related]
20. Ex vivo expansion of CD8+CD56+ and CD8+CD56- natural killer T cells specific for MUC1 mucin. Wajchman HJ; Pierce CW; Varma VA; Issa MM; Petros J; Dombrowski KE Cancer Res; 2004 Feb; 64(3):1171-80. PubMed ID: 14871854 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]